Effect of Vitamin D Treatment on Serum Sclerostin Level

Creative Commons License

Acıbucu F., Dokmetas H. S., Acibucu D. O., Kilicli F., Aydemir M., Çakmak E.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.125, no.9, pp.634-637, 2017 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 125 Issue: 9
  • Publication Date: 2017
  • Doi Number: 10.1055/s-0035-1559790
  • Journal Name: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.634-637
  • Keywords: sclerostin, vitamin D deficiency, parathyroid hormone, PARATHYROID-HORMONE, BONE-FORMATION, PRIMARY HYPERPARATHYROIDISM, CIRCULATING SCLEROSTIN, POSTMENOPAUSAL WOMEN, OSTEOPOROSIS, SOST, PTH, TARGET, GENE
  • Open Archive Collection: AVESIS Open Access Collection
  • Akdeniz University Affiliated: No

Abstract

Objective Sclerostin is an osteocyte-secreted endogenous inhibitor of Wnt signaling. Several systemic and local factors have been suggested as possible regulators of sclerostin expression by osteocytes. In this study, we examined the effect of vitamin D treatment on sclerostin levels.